NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

COR

Cencora Inc

Apr 17 • 04:00PM ET

286.74

Dollar change +2.30
Percentage change 0.81	%

Healthcare • Medical Distribution • USA • NYSE

Peers: CAH MCK HSIC OMI PDCO DXCM BIO HCA LH

| Held by: VTI VOO VO SPY IVV VTV XLV VOE IWP VIG

Scroll to Statements

Index	S&P 500	P/E	40.80	EPS (ttm)	7.03	Insider Own	5.74%	Shs Outstand	193.85M	Perf Week	2.72%
Market Cap	55.60B	Forward P/E	16.92	EPS next Y	16.94	Insider Trans	-11.41%	Shs Float	182.78M	Perf Month	7.87%
Income	1.40B	PEG	3.80	EPS next Q	4.10	Inst Own	91.86%	Short Float	3.79%	Perf Quarter	19.03%
Sales	303.19B	P/S	0.18	EPS this Y	12.22%	Inst Trans	-0.51%	Short Ratio	3.88	Perf Half Y	23.00%
Book/sh	1.17	P/B	245.32	EPS next Y	9.72%	ROA	2.09%	Short Interest	6.93M	Perf Year	20.35%
Cash/sh	17.16	P/C	16.71	EPS next 5Y	10.73%	ROE	245.32%	52W Range	214.77 - 296.65	Perf YTD	27.62%
Dividend Est.	1.96 (0.68%)	P/FCF	-	EPS past 5Y	13.29%	ROI	22.66%	52W High	-3.34%	Beta	0.58
Dividend TTM	2.12 (0.74%)	Quick Ratio	0.54	Sales past 5Y	10.39%	Gross Margin	2.89%	52W Low	33.51%	ATR (14)	6.96
Dividend Ex-Date	Feb 14, 2025	Current Ratio	0.92	EPS Y/Y TTM	-23.54%	Oper. Margin	1.00%	RSI (14)	68.82	Volatility	2.07% 2.53%
Employees	46000	Debt/Eq	35.96	Sales Y/Y TTM	11.64%	Profit Margin	0.46%	Recom	1.89	Target Price	300.50
Option/Short	Yes / Yes	LT Debt/Eq	26.20	EPS Q/Q	-16.00%	Payout	27.07%	Rel Volume	0.89	Prev Close	284.44
Sales Surprise	4.06%	EPS Surprise	6.50%	Sales Q/Q	12.78%	Earnings	May 07 BMO	Avg Volume	1.78M	Price	286.74
SMA20	3.27%	SMA50	9.37%	SMA200	18.47%	Trades		Volume	1,590,754	Change	0.81%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-04-24	Resumed	Mizuho	Outperform	$280
Sep-18-24	Downgrade	BofA Securities	Buy → Neutral	$275 → $245
Feb-26-24	Initiated	Leerink Partners	Outperform	$261
Jan-03-24	Initiated	Barclays	Overweight	$242
Dec-14-23	Initiated	Wells Fargo	Equal Weight	$213
Mar-31-23	Initiated	Citigroup	Buy	$185
Jan-31-23	Resumed	Evercore ISI	Outperform	$185
Oct-11-22	Upgrade	BofA Securities	Neutral → Buy	$160 → $169
Aug-22-22	Resumed	Morgan Stanley	Equal-Weight
Jul-11-22	Downgrade	Evercore ISI	Outperform → In-line	$150
Jun-07-22	Upgrade	Deutsche Bank	Hold → Buy	$167 → $178
May-26-22	Upgrade	Barclays	Equal Weight → Overweight
Apr-12-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$178
Apr-01-22	Resumed	Credit Suisse	Outperform	$180
Feb-04-21	Upgrade	Evercore ISI	In-line → Outperform
Jan-06-21	Upgrade	BofA Securities	Underperform → Neutral
Jun-15-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$112
Apr-23-20	Resumed	Credit Suisse	Outperform	$105
Apr-01-20	Upgrade	JP Morgan	Neutral → Overweight	$93 → $106
Feb-07-20	Upgrade	Robert W. Baird	Neutral → Outperform	$112

Show Previous Ratings

Apr-17-25 12:10PM	Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:52AM	3 Undervalued Medical Device Stocks to Buy in 2025 Amid Tariff Woes (Zacks)
09:50AM	Why Cencora (COR) is a Top Momentum Stock for the Long-Term (Zacks)
Apr-16-25 12:53PM	Jim Cramer: Cencora (COR) Is a "Must-Own" Drug Middleman - Even If It Should Be Digitized Away (Insider Monkey)
Apr-15-25 02:30AM	FTCS: Unconvincing Quality-Focused ETF (Seeking Alpha)
09:48AM	Loading…
Apr-14-25 09:48AM	BAX Stock Declines Despite Latest Product Launch Boosting Patient Care (Zacks)
09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
08:02AM	Beat the Market the Zacks Way: Casey's, Stride, McDonald's in Focus (Zacks)
Apr-13-25 05:43PM	Jim Cramer Likes Cencora (COR) "Middlemen Always Work." (Insider Monkey)
Apr-10-25 09:02AM	Cencora, Inc. (COR): A Bull Case Theory (Insider Monkey)
07:25AM	Here's Why You Should Add Cencora Stock to Your Portfolio Now (Zacks)
05:08AM	Medpace (MEDP) Surges 9.1%: Is This an Indication of Further Gains? (Zacks)
Apr-09-25 08:57AM	Top 3 MedTech Stocks to Weather the Trump Tariff Turbulence (Zacks)
08:00AM	Top 3 S&P 500 Winners in a Losing Market (MarketBeat)
Apr-08-25 12:04PM	ICUI Stock Gains Following Latest FDA Approvals for Precision IV Pumps (Zacks)
07:45AM	Loading…
Apr-07-25 07:45AM	Here's Why You Should Hold Accuray Stock in Your Portfolio for Now (Zacks)
Apr-04-25 12:08PM	Sellers Rule The Roost Amid Tariff Wars, But This Stock Hits A High (Investor's Business Daily)
11:57AM	Danaher Gains From Strength in the Diagnostics Unit Amid Headwinds (Zacks)
08:27AM	4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues (Zacks)
08:06AM	Here's Why You Should Retain DexCom Stock in Your Portfolio for Now (Zacks)
05:14AM	3 Reasons COR Has Explosive Upside Potential (StockStory)
Apr-03-25 03:00PM	MCK Stock Gains as PRISM Acquisition Adds High-Growth Business (Zacks)
09:40AM	Has Cencora, Inc. (COR) Outpaced Other Medical Stocks This Year? (Zacks)
07:54AM	AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK (Zacks)
Apr-02-25 03:00PM	MIST Stock Falls 66% Following Complete Response Letter for Cardamyst (Zacks)
07:47AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
Apr-01-25 01:23PM	GEHC Stock Gains Following Buyout Completion to Boost Its PDx Arm (Zacks)
11:00AM	10 Stocks of the S&P 500 ETF Up More Than 20% in Q1 (Zacks)
08:08AM	Beat the Market the Zacks Way: Amgen, Stride, Sea Limited in Focus (Zacks)
07:21AM	Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now (Zacks)
09:45AM	Loading…
Mar-31-25 09:45AM	Cencora (COR) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
09:34AM	Jim Cramer on Cencora (COR): "Smart Moves in the Drug Middleman Game!" (Insider Monkey)
Mar-28-25 09:48AM	Zacks Industry Outlook Highlights Cencora, Doximity and Pediatrix Medical (Zacks)
09:35AM	Here's Why You Should Retain OPKO Health Stock in Your Portfolio (Zacks)
07:00AM	Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release (Business Wire)
Mar-27-25 07:30PM	Analyst Report: Cencora, Inc. (Morningstar Research)
01:15PM	3 Medical Services Industry Stocks to Buy as AI Fuels Growth (Zacks)
09:40AM	Cencora (COR) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
09:15AM	Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue? (Zacks)
09:05AM	CAH Stock Rises More Than 13% YTD: Should You Buy, Hold or Sell? (Zacks)
09:04AM	DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval (Zacks)
Mar-26-25 07:17AM	DXCM Stock Gains Following New Data on Upcoming G7 CGM Sensor (Zacks)
06:33AM	BDX Stock Declines Following Class I Classification for Alaris Recall (Zacks)
Mar-25-25 05:07AM	Q4 Earnings Highlights: Cencora (NYSE:COR) Vs The Rest Of The Health Insurance Providers Stocks (StockStory)
Mar-24-25 10:47AM	GEHC Stock Falls Despite New Launch to Boost Breast Cancer Diagnosis (Zacks)
Mar-21-25 11:30AM	Why Is Icon PLC (ICLR) Down 8.9% Since Last Earnings Report? (Zacks)
Mar-20-25 12:52PM	GEHC Stock Gains Following Cardiology Solutions Portfolio Expansion (Zacks)
09:05AM	Invesco Health Care Fund Q4 2024 Commentary (SeekingAlpha)
Mar-18-25 12:45PM	Here is Why Growth Investors Should Buy Cencora (COR) Now (Zacks)
Mar-12-25 01:00PM	This Medical Services Stock Looks Relatively Healthy In A Sick Market (Investor's Business Daily)
09:45AM	Here's Why Cencora (COR) is a Strong Growth Stock (Zacks)
Mar-11-25 09:40AM	Here's Why Cencora (COR) is a Strong Value Stock (Zacks)
09:15AM	Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? (Zacks)
Feb-27-25 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Cencora (COR) (Zacks)
Feb-21-25 09:45AM	Why Cencora (COR) is a Top Growth Stock for the Long-Term (Zacks)
Feb-20-25 09:40AM	Here's Why Cencora (COR) is a Strong Value Stock (Zacks)
Feb-11-25 05:30AM	The Magnificent 7 Are So Last Year. Cash Cows Are the New Kings. (The Wall Street Journal)
Feb-06-25 08:37PM	Cencora Announces Common Share Repurchase From Walgreens Boots Alliance (Business Wire)
08:30PM	Walgreens Boots Alliance Early-Settles Certain Prepaid Variable Share Forward Transactions and Sells Related Shares of Cencora For Approximately $300 Million of Proceeds (Business Wire)
Feb-05-25 01:33PM	Analyst Report: Cencora, Inc. (Morningstar Research)
06:30AM	Cencora Reports Fiscal 2025 First Quarter Results (Business Wire)
Feb-03-25 09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
Jan-30-25 02:46PM	Jim Cramer Says Cencora, Inc. (COR) CEO Steve Collis Is 'Really, Really Smart' (Insider Monkey)
Jan-27-25 12:10PM	Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
07:30AM	Harrow Partners with Cencora to Launch "Harrow Cares" Program, Making IHEEZO and TRIESENCE More Accessible and Affordable for Retina Specialists and Their Patients (Business Wire)
Jan-10-25 07:36AM	Walgreens Boots Alliance Maintains Full Year Adj. EPS Guidance - Update (RTT News)
Jan-09-25 09:50AM	Here's Why Cencora (COR) is a Strong Momentum Stock (Zacks)
Jan-08-25 07:30AM	Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release (Business Wire)
Jan-02-25 04:15PM	Cencora Completes Acquisition of Retina Consultants of America (Business Wire)
Jan-01-25 12:00PM	Cencora (COR) Upgraded to Buy: Here's What You Should Know (Zacks)
09:45AM	Here's Why Cencora (COR) is a Strong Growth Stock (Zacks)
Dec-31-24 09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
08:11AM	Is the Options Market Predicting a Spike in Cencora (COR) Stock? (Zacks)
Dec-16-24 09:45AM	Why Cencora (COR) is a Top Growth Stock for the Long-Term (Zacks)
Dec-14-24 06:35AM	Cencora price target lowered to $237 from $249 at Wells Fargo (TipRanks)
Dec-09-24 04:15PM	Cencora Closes $1.8 Billion Senior Notes Offering (Business Wire)
Dec-02-24 10:49PM	Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035 (Business Wire)
02:22PM	Here's Why Cencora (COR) is a Strong Momentum Stock (Zacks)
Nov-25-24 09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
Nov-13-24 06:27PM	McKesson Stock Gets A RS Rating Lift To 75 (Investor's Business Daily)
09:45AM	Here's Why Cencora (COR) is a Strong Growth Stock (Zacks)
Nov-11-24 09:50AM	Why Cencora (COR) is a Top Momentum Stock for the Long-Term (Zacks)
Nov-08-24 03:37PM	Cardinal Health Stock Sees IBD RS Rating Improve To 71 (Investor's Business Daily)
Nov-07-24 07:01AM	Cencora Reports Strong Revenue and EPS Growth in 2024 (TipRanks)
06:36AM	Cencora to acquire Retina Consultants of America for $4.6B in cash (TipRanks)
Nov-06-24 03:07PM	Analyst Report: Cencora, Inc. (Morningstar Research)
09:40AM	Here's Why Cencora (COR) is a Strong Value Stock (Zacks)
06:35AM	Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results (Business Wire)
06:30AM	Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America (Business Wire)
Nov-04-24 08:30AM	Cencora Expands Enterprise Leadership Team with Two Senior Appointments (Business Wire)
Oct-21-24 09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
Oct-15-24 12:10PM	Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Oct-11-24 09:45AM	Here's Why Cencora (COR) is a Strong Growth Stock (Zacks)
Oct-01-24 07:30AM	Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release (Business Wire)
Sep-27-24 07:00AM	Why Drug Distributors Are Buying Cancer Specialists (The Wall Street Journal)
Sep-18-24 07:10PM	Analyst Report: Cencora, Inc. (Morningstar Research)
12:37PM	Top Stock Movers Now: US Steel, VF Corp., ResMed, and More (Investopedia)
Aug-30-24 09:40AM	Here's Why Cencora (COR) is a Strong Value Stock (Zacks)
Aug-22-24 09:45AM	Why Cencora (COR) is a Top Growth Stock for the Long-Term (Zacks)
Aug-15-24 07:30AM	Cencora Elects Frank Clyburn to Its Board of Directors (Business Wire)

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
COLLIS STEVEN H	Executive Chairman	Mar 25 '25	Option Exercise	86.09	12,578	1,082,840	332,491	Mar 26 04:40 PM
COLLIS STEVEN H	Executive Chairman	Mar 25 '25	Sale	269.51	14,578	3,928,917	317,913	Mar 26 04:40 PM
Campbell Elizabeth S	Executive Vice President	Mar 24 '25	Sale	268.28	4,127	1,107,192	14,665	Mar 26 04:38 PM
COLLIS STEVEN H	Director	Mar 25 '25	Proposed Sale	269.51	14,578	3,928,917		Mar 25 10:16 AM
Campbell Elizabeth S	Officer	Mar 24 '25	Proposed Sale	268.28	4,127	1,107,192		Mar 24 10:53 AM
Mauch Robert P.	President & CEO	Mar 18 '25	Option Exercise	86.09	3,226	277,726	54,296	Mar 19 04:38 PM
Mauch Robert P.	President & CEO	Mar 18 '25	Sale	260.93	4,970	1,296,822	49,326	Mar 19 04:38 PM
Mauch Robert P.	Officer	Mar 18 '25	Proposed Sale	260.93	4,970	1,296,822		Mar 18 12:05 PM
Krikorian Lazarus	SVP & Chief Accounting Officer	Mar 10 '25	Sale	260.06	2,000	520,120	20,154	Mar 11 04:07 PM
Krikorian Lazarus	Officer	Mar 10 '25	Proposed Sale	260.06	2,000	520,120		Mar 10 02:09 PM
Mauch Robert P.	President & CEO	Mar 03 '25	Option Exercise	86.09	3,226	277,726	54,296	Mar 04 05:35 PM
Mauch Robert P.	President & CEO	Mar 03 '25	Sale	255.00	4,970	1,267,350	51,070	Mar 04 05:35 PM
Mauch Robert P.	Officer	Mar 03 '25	Proposed Sale	255.00	4,970	1,267,350		Mar 03 03:28 PM
COLLIS STEVEN H	Executive Chairman	Feb 27 '25	Option Exercise	86.09	12,579	1,082,926	332,492	Feb 28 04:05 PM
COLLIS STEVEN H	Executive Chairman	Feb 27 '25	Sale	251.08	14,579	3,660,495	319,913	Feb 28 04:05 PM
COLLIS STEVEN H	Director	Feb 27 '25	Proposed Sale	251.08	14,579	3,660,495		Feb 27 11:26 AM
Battaglia Silvana	Executive Vice President	Feb 21 '25	Sale	242.24	5,000	1,211,200	15,374	Feb 24 05:25 PM
Battaglia Silvana	Officer	Feb 21 '25	Proposed Sale	242.24	5,000	1,211,200		Feb 21 12:18 PM
Walgreens Boots Alliance, Inc.	10% Owner	Feb 06 '25	Sale	244.51	1,286,376	314,531,796	12,570,000	Feb 10 07:35 PM
Walgreens Boots Alliance Holdi	Affiliate	Feb 06 '25	Proposed Sale	246.13	1,081,885	266,284,355		Feb 06 07:55 PM
Battaglia Silvana	Executive Vice President	Dec 20 '24	Sale	228.72	1,678	383,792	20,329	Dec 23 03:47 PM
Battaglia Silvana	Officer	Dec 20 '24	Proposed Sale	228.72	1,678	383,792		Dec 20 01:48 PM
Krikorian Lazarus	SVP & Chief Accounting Officer	Dec 03 '24	Sale	250.41	1,816	454,754	21,988	Dec 04 04:22 PM
Krikorian Lazarus	Officer	Dec 03 '24	Proposed Sale	250.42	1,816	454,754		Dec 03 11:13 AM
Cleary James F	Chief Financial Officer	Nov 27 '24	Option Exercise	89.58	33,877	3,034,702	171,508	Dec 02 04:01 PM
COLLIS STEVEN H	Executive Chairman	Nov 25 '24	Sale	243.97	50,000	12,198,750	326,557	Nov 26 04:31 PM
COLLIS STEVEN H	Director	Nov 25 '24	Proposed Sale	243.98	50,000	12,198,760		Nov 25 04:04 PM
COLLIS STEVEN H	Executive Chairman	Nov 19 '24	Option Exercise	89.58	21,509	1,926,776	328,261	Nov 21 04:49 PM
COLLIS STEVEN H	Executive Chairman	Nov 19 '24	Sale	242.16	21,509	5,208,619	306,752	Nov 21 04:49 PM
COLLIS STEVEN H	Director	Nov 19 '24	Proposed Sale	242.16	21,509	5,208,619		Nov 19 10:00 AM
COLLIS STEVEN H	Executive Chairman	Oct 22 '24	Option Exercise	89.58	21,509	1,926,776	306,597	Oct 23 04:06 PM
COLLIS STEVEN H	Executive Chairman	Oct 22 '24	Sale	235.80	21,509	5,071,822	285,088	Oct 23 04:06 PM
COLLIS STEVEN H	Officer	Oct 22 '24	Proposed Sale	235.80	21,509	5,071,822		Oct 22 10:43 AM
COLLIS STEVEN H	Chairman, President & CEO	Sep 17 '24	Option Exercise	89.58	21,509	1,926,776	306,597	Sep 18 04:37 PM
COLLIS STEVEN H	Chairman, President & CEO	Sep 17 '24	Sale	241.01	21,509	5,183,884	285,088	Sep 18 04:37 PM
Lon Greenberg	Other: Board	Sep 17 '24	Proposed Sale	239.88	4,000	959,520		Sep 17 05:27 PM
COLLIS STEVEN H	Officer	Sep 17 '24	Proposed Sale	241.01	21,509	5,183,884		Sep 17 09:36 AM
COLLIS STEVEN H	Chairman, President & CEO	Aug 20 '24	Option Exercise	89.58	10,754	963,343	295,842	Aug 21 04:08 PM
COLLIS STEVEN H	Chairman, President & CEO	Aug 20 '24	Sale	239.13	10,754	2,571,604	285,088	Aug 21 04:08 PM
COLLIS STEVEN H	Officer	Aug 20 '24	Proposed Sale	239.13	10,754	2,571,604		Aug 20 10:47 AM
Battaglia Silvana	Executive Vice President	Aug 06 '24	Sale	242.69	1,473	357,482	10,948	Aug 07 04:09 PM
Battaglia Silvana	Officer	Aug 06 '24	Proposed Sale	242.69	1,473	357,483		Aug 06 02:08 PM
Walgreens Boots Alliance, Inc.	10% Owner	Aug 01 '24	Sale	240.56	4,438,171	1,067,646,416	19,980,000	Aug 05 06:44 PM
Walgreens Boots Alliance Holdi	Affiliate	Aug 01 '24	Proposed Sale	244.46	3,398,929	830,902,183		Aug 01 08:56 PM
COLLIS STEVEN H	Chairman, President & CEO	Jul 16 '24	Option Exercise	89.58	10,755	963,433	295,843	Jul 17 04:09 PM
COLLIS STEVEN H	Chairman, President & CEO	Jul 16 '24	Sale	222.12	10,755	2,388,901	285,088	Jul 17 04:09 PM
Donato Leslie E	EVP & Chief Strategy Officer	Jul 01 '24	Option Exercise	0.00	1,432	0	9,991	Jul 02 04:08 PM
COLLIS STEVEN H	Chairman, President & CEO	Jun 18 '24	Option Exercise	89.58	10,754	963,343	295,842	Jun 20 04:16 PM
COLLIS STEVEN H	Chairman, President & CEO	Jun 18 '24	Sale	235.76	10,754	2,535,363	285,088	Jun 20 04:16 PM
Clark Gina	Executive Vice President	May 31 '24	Sale	223.86	1,874	419,506	13,284	Jun 03 04:05 PM
Clark Gina	Executive Vice President	May 29 '24	Option Exercise	86.09	27,093	2,332,436	42,251	May 31 04:00 PM
Clark Gina	Executive Vice President	May 29 '24	Sale	216.07	27,093	5,853,985	15,158	May 31 04:00 PM
DURCAN DERMOT MARK	Director	May 24 '24	Buy	218.58	500	109,290	21,876	May 29 04:02 PM
Walgreens Boots Alliance, Inc.	10% Owner	May 22 '24	Sale	215.12	1,859,390	400,000,158	24,418,171	May 24 04:05 PM
COLLIS STEVEN H	Chairman, President & CEO	May 21 '24	Option Exercise	89.58	10,755	963,433	295,843	May 22 04:08 PM
COLLIS STEVEN H	Chairman, President & CEO	May 21 '24	Sale	221.30	10,755	2,380,082	285,088	May 22 04:08 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

COR

Cencora Inc

Upgrade your FINVIZ experience